Literature DB >> 17145303

Functional dynamics of naturally occurring regulatory T cells in health and autoimmunity.

Megan K Levings1, Sarah Allan, Eva d'Hennezel, Ciriaco A Piccirillo.   

Abstract

A network of regulatory T (Treg) cells exists to downregulate immune responses in various inflammatory circumstances and ultimately assure peripheral T cell tolerance. Naturally occurring CD4(+)CD25(+) Treg cell represents a major lymphocyte population engaged in the dominant control of self-reactive T responses and maintenance of tolerance within this network. CD4(+)CD25(+) Treg cells differentiate in the normal thymus as a functionally distinct subpopulation of T cells bearing a broad T cell receptor repertoire endowing these cells with the capacity to recognize a wide spectrum of self-Ag and non-self-Ag specificities. The development of CD4(+)CD25(+) Treg cells is genetically determined, influenced by Ag-specific and nonspecific signals, costimulation, and cytokines that control their activation, expansion, and suppressive activity. Functional abrogation of these cells in vivo, or genetic defects that affect their development or function, unequivocally predisposes animals and humans to the onset of autoimmune and other inflammatory diseases. Studies have shed light in our understanding of the cellular and molecular basis of CD4(+)CD25(+) Treg cell-mediated immune regulation. In this chapter, we discuss the contribution of naturally occurring CD4(+)CD25(+) Treg cells in the induction of immunologic self-tolerance in animal models and humans and attempt to provide a comprehensive overview of recent findings regarding the phenotype, functional dynamics, and effector mechanism of these cells in autoimmune diseases.

Entities:  

Mesh:

Year:  2006        PMID: 17145303     DOI: 10.1016/S0065-2776(06)92003-3

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  17 in total

1.  Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells.

Authors:  Jinxia Zhao; Ru Li; Jing He; Jinxia Shi; Li Long; Zhanguo Li
Journal:  Rheumatol Int       Date:  2008-07-05       Impact factor: 2.631

Review 2.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

Review 3.  Regulatory T Cells in Post-stroke Immune Homeostasis.

Authors:  Arthur Liesz; Christoph Kleinschnitz
Journal:  Transl Stroke Res       Date:  2016-03-31       Impact factor: 6.829

4.  Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.

Authors:  Aisha V Sauer; Immacolata Brigida; Nicola Carriglio; Raisa Jofra Hernandez; Samantha Scaramuzza; Daniela Clavenna; Francesca Sanvito; Pietro L Poliani; Nicola Gagliani; Filippo Carlucci; Antonella Tabucchi; Maria Grazia Roncarolo; Elisabetta Traggiai; Anna Villa; Alessandro Aiuti
Journal:  Blood       Date:  2011-12-19       Impact factor: 22.113

Review 5.  Working out mechanisms of controlled/physiologic inflammation in the GI tract.

Authors:  Keren Rabinowitz; Lloyd Mayer
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 6.  Functional role of regulatory lymphocytes in stroke: facts and controversies.

Authors:  Arthur Liesz; Xiaoming Hu; Christoph Kleinschnitz; Halina Offner
Journal:  Stroke       Date:  2015-03-19       Impact factor: 7.914

7.  Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.

Authors:  Joel Baumgartner; Cara Wilson; Brent Palmer; Don Richter; Anirban Banerjee; Martin McCarter
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

Review 8.  CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Authors:  Bonnie N Dittel
Journal:  Brain Behav Immun       Date:  2008-01-18       Impact factor: 7.217

9.  T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

Authors:  Kanji Watanabe; Pauline N M Mwinzi; Carla L Black; Erick M O Muok; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

10.  Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.

Authors:  Valentina Dal Secco; Cristiana Soldani; Claire Debrat; François Asperti-Boursin; Emmanuel Donnadieu; Antonella Viola; Adelaida Sarukhan
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.